Technical Analysis for ITRM - Iterum Therapeutics plc
Grade | Last Price | % Change | Price Change |
---|---|---|---|
B | 1.43 | 0.00% | 0.00 |
ITRM closed unchanged on Friday, April 19, 2024, on 32 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 10
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Outside Day | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
MACD Bearish Centerline Cross | Bearish | -2.05% | |
Lower Bollinger Band Touch | Weakness | -2.05% | |
Oversold Stochastic | Weakness | -2.05% | |
Fell Below 50 DMA | Bearish | -1.38% |
Alert | Time |
---|---|
Rose Above Previous Day's High | about 11 hours ago |
Outside Day | about 11 hours ago |
Up 5% | about 11 hours ago |
Up 3% | about 11 hours ago |
Fell Below Previous Day's Low | about 11 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/10/2024
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally.
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Stage Pharmaceutical
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Stage Pharmaceutical
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.5 |
52 Week Low | 0.622 |
Average Volume | 188,531 |
200-Day Moving Average | 1.29 |
50-Day Moving Average | 1.51 |
20-Day Moving Average | 1.59 |
10-Day Moving Average | 1.56 |
Average True Range | 0.12 |
RSI (14) | 41.18 |
ADX | 19.84 |
+DI | 19.44 |
-DI | 17.74 |
Chandelier Exit (Long, 3 ATRs) | 1.58 |
Chandelier Exit (Short, 3 ATRs) | 1.77 |
Upper Bollinger Bands | 1.81 |
Lower Bollinger Band | 1.38 |
Percent B (%b) | 0.12 |
BandWidth | 26.86 |
MACD Line | -0.02 |
MACD Signal Line | 0.01 |
MACD Histogram | -0.0316 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.57 | ||||
Resistance 3 (R3) | 1.58 | 1.54 | 1.54 | ||
Resistance 2 (R2) | 1.54 | 1.51 | 1.54 | 1.53 | |
Resistance 1 (R1) | 1.49 | 1.49 | 1.52 | 1.48 | 1.53 |
Pivot Point | 1.45 | 1.45 | 1.47 | 1.45 | 1.45 |
Support 1 (S1) | 1.40 | 1.42 | 1.43 | 1.39 | 1.33 |
Support 2 (S2) | 1.36 | 1.40 | 1.36 | 1.33 | |
Support 3 (S3) | 1.31 | 1.36 | 1.32 | ||
Support 4 (S4) | 1.30 |